# Title

 Food and Drugs. PART 700â€”GENERAL


# ID

 CFR-2018-title21-vol7.Pt. 700


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                               |
|:------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(1000.0, 'USD')]                                                                                                                                                                                    |
| Constraints | ['before', 'within', 'less than', 'after', 'at least', 'no more than']                                                                                                                               |
| Duration    | ['2.0 year', '30.0 month', '5.0 day']                                                                                                                                                                |
| Condition   | ['until', 'unless', 'where', 'subject to', 'when', 'if']                                                                                                                                             |
| Entities    | ['Mercury', 'Failure', 'Cattle', 'Agriculture', 'Safer', 'Society', 'Food', 'Request', 'Scientific', 'Pseudomonas', 'American', 'Evidence', 'New', 'U.S. Customs', 'Chlorofluorocarbon', 'Cosmetic'] |
| Date        | ['1977-09-15', '1939-05-13', '2018-02-01', '1975-12-01', '1973-01-05', '2018-03-05', '1983-05-05', '1984-02-06', '1968-03-15']                                                                       |


# Structured Analysis With Context

 


## Money

| Money           | Context                                                                                                                                                                                                                                                                                                                 |
|:----------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1000.0, 'USD') | (i) The term commercial distribution of a cosmetic product means annual gross sales in excess of $1,000 for that product.                                                                                                                                                                                               |
| (1000.0, 'USD') | (o) System of commercial distribution of a cosmetic product means any distribution outside the establishment manufacturing the product, whether for sale, to promote future sales (including free samples of the product), or to gage consumer acceptance through market testing, in excess of $1,000 in cost of goods. |


## Constraints

| Constraints   | Context                                                                                                                                |
|:--------------|:---------------------------------------------------------------------------------------------------------------------------------------|
| within        | respect to any cosmetic preparation containing bithionol shipped within the jurisdiction of the act after March 15,                    |
| after         | bithionol shipped within the jurisdiction of the act after  March 15, 1968.                                                            |
| after         | the lungs by inhalation and by intestinal absorption after  ingestion.                                                                 |
| after         | allergen and sensitizer, and skin irritation is common after  topical application.                                                     |
| within        | as skin-bleaching, beauty, or facial preparation is misbranded within the meaning of sections 502(a), 502(f)(1) and (2),               |
| within        | Any such preparation shipped  within the jurisdiction of the Act after January 5,                                                      |
| after         | preparation shipped within the jurisdiction of the Act after January 5, 1973 will be the subject of                                    |
| within        | 11, 1944) and will regard as adulterated  within the meaning of section 601(a) of the Act                                              |
| no more than  | (i) It is a cosmetic containing  no more than a trace amount of mercury and such trace                                                 |
| less than     | under conditions of good manufacturing practice and is less than 1 part per million (0.0001 percent), calculated as                    |
| no more than  | (i) It is a cosmetic containing  no more than a trace amount of mercury and such trace                                                 |
| within        | product containing vinyl chloride as an ingredient shipped within the jurisdiction of the Act is subject to                            |
| after         | ingredient that is initially introduced into interstate commerce after December 1, 1975, that is not in compliance                     |
| after         | Any such cosmetic product introduced in interstate commerce after  September 15, 1977 is subject to regulatory action.                 |
| after         | the likelihood of substitution of a tamper-resistant feature after tampering, the indicator or barrier to entry is                     |
| after         | vaginal tablets) packaged for retail sale on or after that date, except for the requirement in paragraph                               |
| after         | vaginal tablet packaged for retail sale on or after  that date.                                                                        |
| after         | cosmetic product packaged for retail sale on or after that date, except that the requirement for a                                     |
| after         | cosmetic product packaged for retail sale on or after that date, except that the requirement for a                                     |
| after         | affected cosmetic product held for sale on or after that date that was packaged for retail sale                                        |
| before        | that date that was packaged for retail sale before  May 5, 1983.                                                                       |
| after         | Products packaged for retail sale  after May 5, 1983, as required to be in                                                             |
| no more than  | not include the following: (i) Tallow that contains no more than 0.15 percent insoluble impurities, tallow derivatives, gelatin, hides |
| no more than  | are not prohibited cattle materials or must contain no more than 0.15 percent insoluble impurities as determined by the                |
| at least      | ileum is removed by a procedure that removes at least 80 inches of the uncoiled and trimmed small                                      |
| after         | (2) Records must be retained for 2 years  after  the date they were created.                                                           |
| within        | the importer of record must, if requested, provide within 5 days records sufficient to demonstrate that the                            |
| within        | a structure or function of the body comes within the definition of a drug in section 201(g)(1)                                         |
| at least      | of this section shall appear prominently and conspicuously at least once in the labeling in conjunction with the                       |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.0 year   | In a 2-year animal inhalation study sponsored by the National Toxicology Program, methylene chloride produced a significant increase in benign and malignant tumors of the lung and liver of male and female mice.                                                                                                                                                                 |
| 30.0 month | (5) Specified risk material means the brain, skull, eyes, trigeminal ganglia, spinal cord, vertebral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar vertebrae, and the wings of the sacrum), and dorsal root ganglia of cattle 30 months of age and older and the tonsils and distal ileum of the small intestine of all cattle. |
| 2.0 year   | (2) Records must be retained for 2 years after the date they were created.                                                                                                                                                                                                                                                                                                         |
| 5.0 day    | If a cosmetic is manufactured from, processed with, or otherwise contains, cattle material, then the importer of record must, if requested, provide within 5 days records sufficient to demonstrate that the cosmetic is not manufactured from, processed with, or does not otherwise contain, prohibited cattle material.                                                         |


## Condition

| Condition   | Context                                                                                                                 |
|:------------|:------------------------------------------------------------------------------------------------------------------------|
| subject to  | drug or device or component thereof is also subject to  the requirements of Chapter V of the act.                       |
| where       | (j) Establishment means a place of business  where  cosmetic products are manufactured or packaged.                     |
| when        | the act shall be applicable to such terms when  used in the regulations in this subchapter.                             |
| subject to  | file with the Food and Drug Administration and subject to public inspection; (2) Designed to determine that there       |
| where       | Food and Drug Administration at reasonable times and, where an audit is conducted, such audit shows that                |
| when        | has been determined to be unfounded or spurious when  evaluated by a filed screening procedure.                         |
| when        | bithionol is capable of causing photosensitivity in man when used topically and that in some instances the              |
| unless      | 601(a) of the Act any cosmetic containing mercury unless the cosmetic meets the conditions of paragraph (d)(2)          |
| where       | toxicity, manifested by dizziness, headache, disorientation, and unconsciousness where  inhaled at high concentrations. |
| subject to  | shipped within the jurisdiction of the Act is subject to  regulatory action.                                            |
| subject to  | is not in compliance with this section is subject to  regulatory action.                                                |
| subject to  | The lung is an organ, like skin,  subject to  the development of granulomas.                                            |
| until       | will not reveal the presence of granulomatous changes until they have become advanced and, in some cases,               |
| subject to  | in interstate commerce after September 15, 1977 is subject to  regulatory action.                                       |
| subject to  | chloroform as an ingredient is adulterated and is subject to regulatory action under sections 301 and 601(a) of         |
| subject to  | as an ingredient is deemed adulterated and is subject to regulatory action under sections 301 and 601(a) of             |
| if          | shall package the product in a tamper-resistant package, if this product is accessible to the public while              |
| if          | having an indicator or barrier to entry which, if breached or missing, can reasonably be expected to                    |
| when        | shall be designed to and shall remain intact when handled in a reasonable manner during manufacture, distribution,      |
| if          | be so placed that it will be unaffected if the tamper-resistant feature of the package is breached                      |
| when        | Act (the FD&amp;C Act) apply to such terms when  used in this part.                                                     |
| if          | small intestine is not considered prohibited cattle material if the distal ileum is removed by a procedure              |
| if          | Electronic records are considered to be reasonably accessible  if  they are accessible from an onsite location.         |
| when        | cosmetic was manufactured in accordance with this section. when                                                         |
| if          | cattle material, then the importer of record must, if requested, provide within 5 days records sufficient to            |
| subject to  | under other applicable statutory provisions or regulations remain subject to  part 11 of this chapter.                  |
| subject to  | granted by FDA under this paragraph will be subject to future review by FDA, and may be revoked                         |
| if          | future review by FDA, and may be revoked if  FDA determines that it is no longer appropriate.                           |
| when        | and other harmful effects due to the sun when used in conjunction with limiting sun exposure and                        |
| subject to  | product's labeling generally causes the product to be subject to  regulation as a drug.                                 |
| if          | To avoid consumer misunderstanding,  if a cosmetic product contains a sunscreen ingredient and                          |


## Entities

| Entities           | Context                                                                                                                                             |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------|
| Food               | Food  and Drugs.                                                                                                                                    |
| New                | New evidence of clinical experience and photopatch tests indicate                                                                                   |
| Mercury            | Mercury is absorbed from topical application and is accumulated                                                                                     |
| Mercury            | Mercury is a potent allergen and sensitizer, and skin                                                                                               |
| Cosmetic           | Cosmetic preparations containing mercury compounds are often applied with                                                                           |
| Pseudomonas        | because mercury compounds are exceptionally effective in preventing Pseudomonas  contamination of cosmetics and                                     |
| Pseudomonas        | because mercury compounds are exceptionally effective in preventing Pseudomonas  contamination of cosmetics and                                     |
| Evidence           | Evidence indicates that vinyl chloride inhalation can result in                                                                                     |
| Safer              | Safer  alternative antimicrobial agents are available.                                                                                              |
| Evidence           | Evidence indicates that certain zirconium compounds have caused human                                                                               |
| Scientific         | Scientific literature indicates that chloroform is absorbed from the                                                                                |
| Chlorofluorocarbon | Chlorofluorocarbon  propellants.                                                                                                                    |
| Request            | clearly identified on the envelope as a &#8220; Request for Exemption from Tamper-resistant Rule.&#8221; The petition is                            |
| Cosmetic           | Cosmetic products covered by this section are required to                                                                                           |
| Cattle             | products, and milk and milk products, and (ii) Cattle materials inspected and passed from a country designated                                      |
| Agriculture        | in 9 CFR 319.5, the U.S. Department of Agriculture regulation that prescribes the standard of identity for                                          |
| American           | entitled &#8220;Insoluble Impurities&#8221; (AOCS Official Method Ca 3a-46), American Oil Chemists' Society (AOCS), 5th Edition, 1997, incorporated |
| Society            | (AOCS Official Method Ca 3a-46), American Oil Chemists' Society (AOCS), 5th Edition, 1997, incorporated by reference in                             |
| U.S. Customs       | (6) When filing entry with  U.S. Customs and Border Protection, the importer of record of                                                           |
| Failure            | Failure of a manufacturer or processor to operate in                                                                                                |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1968-03-15 | (b) Regulatory proceedings may be initiated with respect to any cosmetic preparation containing bithionol shipped within the jurisdiction of the act after March 15, 1968.                                                                                                                                                                                                                                                                                                                                                      |
| 1939-05-13 | Therefore:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|            |               (1) The Food and Drug Administration withdraws the opinion expressed in trade correspondence TC-9 (issued May 13, 1939) and concludes that any product containing mercury as a skin-bleaching agent and offered for sale as skin-bleaching, beauty, or facial preparation is misbranded within the meaning of sections 502(a), 502(f)(1) and (2), and 502(j), and may be a new drug without approval in violation of section 505 of the Federal Food, Drug, and Cosmetic Act.                                     |
| 1973-01-05 | Any such preparation shipped within the jurisdiction of the Act after January 5, 1973 will be the subject of regulatory action.                                                                                                                                                                                                                                                                                                                                                                                                 |
| 2018-03-05 | (a) Halogenated salicylanilides (tribromsalan (TBS,3,4&#8242;,5-tribromosalicylanilide), dibromsalan (DBS,4&#8242;5-dibromosalicylanilide), metabromsalan (MBS, 3,5-dibromosalicylanilide) and 3,3&#8242;,4,5&#8242;-tetrachlorosalicylanilide (TCSA)) have been used as antimicrobial agents for a variety of purposes in cosmetic products.                                                                                                                                                                                   |
| 1975-12-01 | (c) Any cosmetic product containing these halogenated salicylanilides as an ingredient that is initially introduced into interstate commerce after December 1, 1975, that is not in compliance with this section is subject to regulatory action.                                                                                                                                                                                                                                                                               |
| 1977-09-15 | (c) Any such cosmetic product introduced in interstate commerce after September 15, 1977 is subject to regulatory action.                                                                                                                                                                                                                                                                                                                                                                                                       |
| 2018-02-01 | (i) The packaging requirement in paragraph (b) of this section is effective on Feburary 7, 1983 for each affected cosmetic product (except vaginal tablets) packaged for retail sale on or after that date, except for the requirement in paragraph (b) of this section for a distinctive indicator or barrier to entry.                                                                                                                                                                                                        |
| 1983-05-05 | (ii) The packaging requirement in paragraph (b) of this section is effective on May 5, 1983 for each cosmetic product that is a vaginal tablet packaged for retail sale on or after that date.                                                                                                                                                                                                                                                                                                                                  |
| 1983-05-05 | The requirement in paragraph (b) of this section that the indicator or barrier to entry be distinctive by design and the requirement in paragraph (c) of this section for a labeling statement are effective on May 5, 1983 for each affected cosmetic product packaged for retail sale on or after that date, except that the requirement for a specific label reference to any identifying characteristic is effective on February 6, 1984 for each affected cosmetic product packaged for retail sale on or after that date. |
| 1984-02-06 | The requirement in paragraph (b) of this section that the indicator or barrier to entry be distinctive by design and the requirement in paragraph (c) of this section for a labeling statement are effective on May 5, 1983 for each affected cosmetic product packaged for retail sale on or after that date, except that the requirement for a specific label reference to any identifying characteristic is effective on February 6, 1984 for each affected cosmetic product packaged for retail sale on or after that date. |
| 1984-02-06 | The tamper-resistant packaging requirement of paragraph (b) of this section is effective February 6, 1984 for each affected cosmetic product held for sale on or after that date that was packaged for retail sale before May 5, 1983.                                                                                                                                                                                                                                                                                          |
| 1983-05-05 | The tamper-resistant packaging requirement of paragraph (b) of this section is effective February 6, 1984 for each affected cosmetic product held for sale on or after that date that was packaged for retail sale before May 5, 1983.                                                                                                                                                                                                                                                                                          |
| 1983-05-05 | Products packaged for retail sale after May 5, 1983, as required to be in compliance with all aspects of the regulations without regard to the retail level effective date.                                                                                                                                                                                                                                                                                                                                                     |


